Evaluation of the NovaplexTM Tropical Fever Virus Assay
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188398 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Giuseppe Sberna und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Laboratories of Biosafety, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy. Hauptthemen laut MEDLINE: Multiplex Polymerase Chain Reaction. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, National Institute for Infectious Diseases “Lazzaro Spallanzani”.
Abstract (Originalsprache)
Arboviral infections represent a growing challenge for global public health due to vector expansion, globalization, and climate change. Dengue (DENV), Zika (ZIKV), Chikungunya (CHIKV), and West Nile virus (WNV) often co-circulate and present overlapping clinical manifestations, making rapid and accurate etiological diagnosis difficult. In this context, multiplex real-time RT-PCR assays can support clinical management and epidemiological surveillance. In this study, analytical and preliminary retrospective comparisons of the NovaplexTM Tropical Fever Virus Assay, a multiplex RT-PCR system designed for the simultaneous detection of DENV, ZIKV, CHIKV, and WNV, were performed. Analytical sensitivity was assessed using serial viral-stock dilutions and Probit regression analysis to estimate the limit of detection (LOD) at a 95% probability. The LOD was 4.41 Log copies/mL for WNV2, 3.67 for DENV2, 2.57 for ZIKV, and 3.43 for CHIKV in PBS. In spiked plasma or urine, LODs ranged from 2.04 to 4.79 Log copies/mL. No cross-reactivity with Usutu virus was observed under the conditions tested. In a retrospective comparison of 34 clinical specimens with singleplex assays, agreement was the highest for WNV, substantial for CHIKV, and limited for DENV. These findings support Novaplex as a complementary tool for arboviral diagnosis and surveillance, although further clinical studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Virology and Laboratories of Biosafety, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
ORCID-Profile: Giuseppe Sberna, Francesca Colavita, Maria Beatrice Valli, Fabrizio Carletti, Silvia Meschi, Claudia Minosse, Giulia Berno, Flavia Smoquina, Lavinia Fabeni, Fabrizio Maggi
Förderung
- Ministero della Salute
- National Institute for Infectious Diseases “Lazzaro Spallanzani”
Zitieren
APA
Sberna, G., Colavita, F., Valli, M. B., Brillo, F., Carletti, F., Meschi, S., Mija, C., Minosse, C., Valeriani, V., Rozera, G., Berno, G., Smoquina, F., Fabeni, L., Maggi, F., & Lalle, E. (2026). Evaluation of the NovaplexTM Tropical Fever Virus Assay. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188398
Vancouver
Sberna G, Colavita F, Valli MB, Brillo F, Carletti F, Meschi S, et al. Evaluation of the NovaplexTM Tropical Fever Virus Assay. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188398
BibTeX
@article{Sberna2026,
author = {Sberna, Giuseppe and Colavita, Francesca and Valli, Maria Beatrice and Brillo, Fabiano and Carletti, Fabrizio and Meschi, Silvia and Mija, Cosmina and Minosse, Claudia and Valeriani, Valentina and Rozera, Gabriella and Berno, Giulia and Smoquina, Flavia and Fabeni, Lavinia and Maggi, Fabrizio and Lalle, Eleonora},
title = {Evaluation of the NovaplexTM Tropical Fever Virus Assay},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188398}
}
EUVIMED